Mechanisms of action and therapeutic potential of strontium in bone

被引:557
|
作者
Marie, PJ
Ammann, P
Boivin, G
Rey, C
机构
[1] Hop Lariboisiere, CNRS, INSERM U349, F-75475 Paris 10, France
[2] Hop Cantonal Geneva, Div Malad Ossueses, Dept Innere Med, Geneva, Switzerland
[3] Fac Med R Laennec, INSERM U403, Lyon, France
[4] INP, Ecole Natl Super Chim, Toulouse, France
关键词
strontium; formation; osteopenia; resorption; bone;
D O I
10.1007/s002230010055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The processes of bone resorption and formation are tightly governed by a variety of systemic and local regulatory agents. In addition, minerals and trace elements affect bone formation and resorption through direct or indirect effects on bone cells or bone mineral. Some trace elements closely chemically related to calcium, such as strontium (Sr), have pharmacological effects on bone when present at levels higher than those required for normal cell physiology. Indeed, strontium was found to exert several effects on bone cells. In addition to its antiresorptive activity, strontium was found to have anabolic activity in bone, and this may have significant beneficial effects on bone balance in normal and osteopenic animals. Accordingly, strontium has been thought to have potential interest in the treatment of osteoporosis. This review summarizes the mechanisms of action of strontium on bone cells, the evidence for its beneficial effects on bone mass in vivo, and its potential therapeutic effects in osteopenic disorders.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 50 条
  • [41] STRONTIUM RANELATE: THE FIRST DUAL ACTION BONE AGENT
    Chunder, R.
    SOUTH AFRICAN FAMILY PRACTICE, 2006, 48 (06) : 52 - 56
  • [42] Strontium ranelate: Mode of action and benefits for bone quality
    Ammann, P
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S105 - S106
  • [43] Action and therapeutic potential of oxyntomodulin
    Pocai, Alessandro
    MOLECULAR METABOLISM, 2014, 3 (03): : 241 - 251
  • [44] Calcimimetics, mechanisms of action and therapeutic applications
    Ureña, P
    Legoupil, N
    de Vernejoul, MC
    PRESSE MEDICALE, 2005, 34 (15): : 1095 - 1100
  • [45] Mechanisms of action of therapeutic antibodies for cancer
    Redman, J. M.
    Hill, E. M.
    AlDeghaither, D.
    Weiner, L. M.
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 28 - 45
  • [46] Mechanisms of action and patentability of therapeutic oligonucleotides
    Crouvezier, Nicolas
    Marie, Anne-Celine
    Moumne, Lara
    M S-MEDECINE SCIENCES, 2023, 39 (02): : 111 - 118
  • [47] POSSIBLE MECHANISMS OF THE THERAPEUTIC ACTION OF CORTISONE
    LONG, DA
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1955, 6 (4-6): : 337 - 355
  • [48] Curcumin as a Natural Therapeutic Agent: A Rapid Review of Potential Clinical Uses and Mechanisms of Action
    Mohajeri, Mohammad
    Momenai, Reza
    Karami-Mohajeri, Somayyeh
    Ohadi, Mandana
    Estabragh, Mohammad Amin Raeisi
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2025, 24 (01):
  • [49] Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action
    Ostadkarampour, Mahyar
    Putnins, Edward E.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Long non-coding RNAs in osteoporosis: from mechanisms of action to therapeutic potential
    Hou, Jianglin
    Liu, Da
    Zhao, Jihui
    Qin, Sen
    Chen, Senxiang
    Zhou, Zimo
    HUMAN CELL, 2023, 36 (03) : 950 - 962